跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Rasagiline Mesylate Tablets
Approved
化学药品
Rasagiline Mesylate Tablets
Teva Pharmaceutical Industries Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Mar 1, 2022
Approval ID
8H9hNEwMLAz
Company
Teva Pharmaceutical Industries Ltd.
Type
化学药品
Approval Details
Approval Id
8H9hNEwMLAz
Approval Number
国药准字HJ20170337
Generic Name
甲磺酸雷沙吉兰片
Generic Name En
Rasagiline Mesylate Tablets
Trade Name
安齐来
Brand Name
安齐来
Drug Type
化学药品
Dosage Form
片剂
Strength
1mg(以雷沙吉兰计)
Reg Date
2022-03-01
Expired Date
2027-02-28
Company Name
Teva Pharmaceutical Industries Ltd.
Production Company Name
Teva Pharmaceutical Industries Ltd.
Company Detail Path
/organization/teva-pharmaceutical-industries-ltd
Production Company Detail Path
/organization/teva-pharmaceutical-industries-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 1, 2022
Approval ID
8H9hNEwMLAz
Type
化学药品
Back to NMPA Approvals
安齐来 - NMPA Drug Approval Details